Class C Acinetobacter-derived cephalosporinases(ADCs) represent an important target for inhibition in the multidrug-resistantpathogen Acinetobacter baumannii. ManyADC variants have emerged, and characterization of their structuraland functional differences is essential. Equally as important is thedevelopment of compounds that inhibit all prevalent ADCs despite thesedifferences. The boronic acid transition state inhibitor, MB076, a novel heterocyclic triazole with improved plasma stability, wassynthesized and inhibits seven different ADC & beta;-lactamase variantswith K (i) values MB076 acted synergistically in combination with multiple cephalosporinsto restore susceptibility. ADC variants containing an alanine duplicationin the & omega;-loop, specifically ADC-33, exhibited increased activityfor larger cephalosporins, such as ceftazidime, cefiderocol, and ceftolozane.X-ray crystal structures of ADC variants in this study provide a structuralcontext for substrate profile differences and show that the inhibitoradopts a similar conformation in all ADC variants, despite small changesnear their active sites.

Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits Acinetobacter-Derived Cephalosporinase Variants with an Expanded-Substrate Spectrum / Powers, R. A.; June, C. M.; Fernando, M. C.; Fish, E. R.; Maurer, O. L.; Baumann, R. M.; Beardsley, T. J.; Taracila, M. A.; Rudin, S. D.; Hujer, K. M.; Hujer, A. M.; Santi, N.; Villamil, V.; Introvigne, M. L.; Prati, F.; Caselli, E.; Bonomo, R. A.; Wallar, B. J.. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 66:13(2023), pp. 8510-8525. [10.1021/acs.jmedchem.3c00144]

Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits Acinetobacter-Derived Cephalosporinase Variants with an Expanded-Substrate Spectrum

Santi N.
Investigation
;
Villamil V.
Investigation
;
Introvigne M. L.
Membro del Collaboration Group
;
Prati F.
Conceptualization
;
Caselli E.
Writing – Original Draft Preparation
;
2023

Abstract

Class C Acinetobacter-derived cephalosporinases(ADCs) represent an important target for inhibition in the multidrug-resistantpathogen Acinetobacter baumannii. ManyADC variants have emerged, and characterization of their structuraland functional differences is essential. Equally as important is thedevelopment of compounds that inhibit all prevalent ADCs despite thesedifferences. The boronic acid transition state inhibitor, MB076, a novel heterocyclic triazole with improved plasma stability, wassynthesized and inhibits seven different ADC & beta;-lactamase variantswith K (i) values MB076 acted synergistically in combination with multiple cephalosporinsto restore susceptibility. ADC variants containing an alanine duplicationin the & omega;-loop, specifically ADC-33, exhibited increased activityfor larger cephalosporins, such as ceftazidime, cefiderocol, and ceftolozane.X-ray crystal structures of ADC variants in this study provide a structuralcontext for substrate profile differences and show that the inhibitoradopts a similar conformation in all ADC variants, despite small changesnear their active sites.
2023
66
13
8510
8525
Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits Acinetobacter-Derived Cephalosporinase Variants with an Expanded-Substrate Spectrum / Powers, R. A.; June, C. M.; Fernando, M. C.; Fish, E. R.; Maurer, O. L.; Baumann, R. M.; Beardsley, T. J.; Taracila, M. A.; Rudin, S. D.; Hujer, K. M.; Hujer, A. M.; Santi, N.; Villamil, V.; Introvigne, M. L.; Prati, F.; Caselli, E.; Bonomo, R. A.; Wallar, B. J.. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 66:13(2023), pp. 8510-8525. [10.1021/acs.jmedchem.3c00144]
Powers, R. A.; June, C. M.; Fernando, M. C.; Fish, E. R.; Maurer, O. L.; Baumann, R. M.; Beardsley, T. J.; Taracila, M. A.; Rudin, S. D.; Hujer, K. M....espandi
File in questo prodotto:
File Dimensione Formato  
Final_paper_acs.jmedchem.3c00144.pdf

Open access

Descrizione: Articolo Open access
Tipologia: Versione pubblicata dall'editore
Dimensione 7.51 MB
Formato Adobe PDF
7.51 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1321687
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact